RSPO3's involvement in modulating adipose tissue dynamics via the WNT signaling pathway may contribute to gene-environment interplay, potentially affecting body fat distribution patterns and susceptibility to metabolic diseases like obesity. This evidence concerns the gene RSPO3 and metabolic disease.